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Abstract
Regarded as an emerging diarrheal micropathogen, Vibrio cholerae serogroup O139 was first identified in 1992 and has
become an important cause of cholera epidemics over the last two decades. O139 strains have been continually isolated
since O139 cholera appeared in China in 1993, from sporadic cases and dispersed foodborne outbreaks, which are the
common epidemic types of O139 cholera in China. Antibiotic resistance profiles of these epidemic strains are required for
development of clinical treatments, epidemiological studies and disease control. In this study, a comprehensive
investigation of the antibiotic resistance of V. cholerae O139 strains isolated in China from 1993 to 2009 was conducted. The
initial O139 isolates were resistant to streptomycin, trimethoprim-sulfamethoxazole and polymyxin B only, while multidrug
resistance increased suddenly and became common in strains isolated after 1998. Different resistance profiles were
observed in the isolates from different years. In contrast, most V. cholerae O1 strains isolated in the same period were much
less resistant to these antibiotics and no obvious multidrug resistance patterns were detected. Most of the non-toxigenic
strains isolated from the environment and seafood were resistant to four antibiotics or fewer, although a few multidrug
resistant strains were also identified. These toxigenic O139 strains exhibited a high prevalence of the class I integron and the
SXT element, which were rare in the non-toxigenic strains. Molecular subtyping of O139 strains showed highly diverse
pulsed-field gel electrophoresis patterns, which may correspond to the epidemic state of sporadic cases and small-scale
outbreaks and complex resistance patterns. Severe multidrug resistance, even resistance transfers based on mobile
antibiotic resistance elements, increases the probability of O139 cholera as a threat to public health. Therefore, continual
epidemiological and antibiotic sensitivity surveillance should focus on the occurrence of multidrug resistance and frequent
microbial population shifts in O139 strains.
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Introduction
Cholera is a major public health problem in developing
countries. The cholera toxin of the Vibrio cholerae strains, encoded
by ctxAB in the lysogenic bacteriophage CTXW, is the major
virulence factor responsible for diarrhea. Historically, only the V.
cholerae O1 serogroup has been recognized to be associated with
epidemics in the sixth and seventh cholera pandemics. The V.
cholerae O139 strains emerged as a new serogroup in southern
India and Bangladesh in late 1992 and rapidly spread to all
cholera-endemic areas in India and neighboring countries [1,2]. A
new clone of the V. cholerae O1 El Tor biotype replaced the O139
serogroup as the dominant serogroup causing cholera in 1994,
when few O139 cholera cases were reported [3]. During late 1995
and 1996, both V. cholerae O1 and O139 cases were detected in
Bangladesh and since 1996, cholera in Bangladesh has been
caused predominantly by V. cholerae O1 El Tor [4]. An extensive
outbreak of cholera caused predominantly by V. cholerae O139
recurred in some regions of Bangladesh in 2002 [4]. A similar
cholera outbreak also appeared in some parts of India during
August, 1996 and September, 1997 and during September and
October of 1998, when O139 cholera cases were predominantly
observed [5,6,7,8,9]. The first outbreak caused by serogroup O139
strains in China occurred in Xinjiang in 1993, when approxi-
mately 200 cases were reported [10]. Unlike the explosive
epidemics in Bangladesh and India, the O139 cholera outbreaks
spanning different regions in China were rare. Limited foodborne
outbreaks associated with food poisoning and sporadic cases in
various regions, especially in southeastern China, were frequently
reported and have been expanding since 1998. To date, serogroup
O139 continues to be confined to Southeast Asia, while the threat
of global expansion is ever-present.
The primary treatment for cholera is rehydration with oral or
intravenous fluids. Antibiotic therapy can shorten the duration
and severity of diarrhea but also aggravates the appearance of
antibiotic resistance [11]. Analysis of O139 isolates revealed
interesting patterns of resistance to various common antibiotics
[9,12]. In contrast to V. cholerae O1, the initial O139 isolates
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zole [2] due to the presence of a 62 kb integrating conjugative
element, termed SXT [13]. V. cholerae O139 isolates have been
frequently reported to be resistant to various commonly used
antibiotics, such as ampicillin, tetracycline, chloramphenicol,
nalidixic acid, nitrofurantoin and even to ciprofloxacin
[12,14,15,16,17]. According to a previous report, almost all
352 V. cholerae O139 strains isolated from hospitalized clinical
cases and environmental sources from 1997 to 1998 were
reported to be resistant to ampicillin, furazolidone and
neomycin [18]. Ofloxacin-resistant O139 strains were reported
in Hong Kong in 1998 [19]. Furthermore, the multidrug
resistant (MDR) V. cholerae has received increasing worldwide
attention especially in the epidemic regions [4].
The mechanisms of antimicrobial resistance are associated with
intrinsic resistance, acquired genetic determinants of resistance
and mutations. The spread of MDR V. cholerae O139 strains has
been attributed to the mobilization of drug resistance genetic
elements and MDR in V. cholerae has traditionally been described
upon acquisition of R plasmids [17,20,21]. Other genetic
elements, including the class I integron and the SXT element,
have been reported to be closely associated with the spread of
genetic elements by mediating antibiotic resistance in V. cholerae
[22,23].
Antibiotic resistance in V. cholerae O139 strains in China has
not been comprehensively reported previously. In this study,
antimicrobial susceptibility to 16 different antibiotics was
investigated among V. cholerae O139 strains isolated in China
from 1993 to 2009, especially in comparison with the
contemporaneous serogroup O1 strains. Mobile genetic elements
associated with antibiotic resistance were also characterized to
further elucidate the mechanisms of antibiotic resistance in
serogroup O139 strains.
Results
Antibiotic Susceptibility of Toxigenic and Non-toxigenic
O139 Strains
PCR analysis of the cholera toxin revealed that 85.3% (290/
340) of the V. cholerae O139 strains in this study were positive for
the 749 bp amplicon. Most toxigenic O139 strains were isolated
from patient samples, while non-toxigenic strains were almost
isolated from environmental water and animals. In order to
characterize the variance in antibiotic resistance between toxigenic
strains and non-toxigenic strains, the antibiotic susceptibility
patterns of 340 V. cholerae O139 isolates were analyzed (Table 1).
Briefly, high rates of resistance were detected among toxigenic and
non-toxigenic O139 strains to erythromycin, streptomycin and
polymyxin B (94.1%/98.0%, 97.9%/88.0% and 99.0%/86.0%
respectively). Comparative analysis revealed significantly higher
rates of resistance to nalidixic acid, trimethoprim-sulfamethoxa-
zole, tetracycline, chloramphenicol, azithromycin and kanamycin
among the toxigenic O139 strains compared with the non-
toxigenic strains (P,0.01, x
2 test). A high rate of resistance
(.60%) to ampicillin was detected with less variance among both
the toxigenic and non-toxigenic O139 strains. Most toxigenic and
non-toxigenic strains were susceptible to new generation antibi-
otics, such as ciprofloxacin and doxycycline. Only nine toxigenic
isolates were resistant to ciprofloxacin, with a minimum inhibitory
concentration (MIC) of 4 to 8 mg/ml. Twenty-two toxigenic and
one non-toxigenic isolates were resistant to doxycycline, with
MICs ranging from 16 to 32 mg/ml. No isolates were resistant to
cefuroxime, cefixime and ceftriaxone and few strains were resistant
to cephalothin.
The toxigenic O139 strains isolated from the first outbreak in
Xinjiang in 1993 exhibited a higher rate of resistance to
streptomycin, trimethoprim-sulfamethoxazole, erythromycin and
polymyxin B, which is consistent with previous reports [2]. The
rates of resistance to these four antibiotics remained high and
stable over the period 1993 to 2009. As shown in Figure 1, most
toxigenic O139 strains were susceptible to ampicillin, nalidixic
acid, tetracycline, chloramphenicol and kanamycin during the
period from 1993 to 1997, while the rates of resistance to these
antibiotics increased dramatically, to more than 60% in 1998 and
have fluctuated at high levels subsequently. Single-dose azithro-
mycin was used as an effective treatment for severe cholera in
adults [21] until the resistant rates increased dramatically and
peaked in 2003. Interestingly, the resistance rates to ampicillin,
chloramphenicol and azithromycin have decreased significantly in
recent years. Most toxigenic O139 strains remain susceptible to
cephalothin and ciprofloxacin, while toxigenic O139 strains have
exhibited increasing resistance to doxycycline in recent years. The
recent alteration in resistance to ampicillin, chloramphenicol,
azithromycin and doxycycline may associate with the common
usage of these antibiotics in clinical treatments and population shift
of the O139 strains with different resistance patterns. In contrast to
toxigenic strains, the non-toxigenic O139 strains showed no
obvious variance in the resistance to these antibiotics over the
period from 1994 to 2009.
Multidrug Resistance Patterns of Toxigenic and Non-
toxigenic O139 Strains
The absence of susceptibility to ampicillin, tetracycline,
chloramphenicol, erythromycin, kanamycin, nalidixic acid, strep-
tomycin, trimethoprim-sulfamethoxazole and polymyxin B (AMP-
TCY-CHL-ERY-KAN-NAL-STR-SXT-PB) represented the most
common pattern of multiple-drug resistance (MDR) and 153
O139 isolates (45.0%) conformed to this pattern (Table S1).
Within this pattern group, 151 isolates were positive for cholera
toxin, while only two non-toxigenic strains isolated in 2007
exhibited this MDR pattern. The strains exhibiting this pattern of
multiple antibiotic resistances first emerged in 1998, and have
accounted for approximately half of the strains isolated each year
over the period from 1998 to 2008, indicating a predominant
dissemination of this MDR pattern. Nineteen toxigenic strains
exhibited the second MDR type of ERY-KAN-NAL-STR-SXT-
TCY-PB. Only 33 toxigenic strains were resistant to four types of
antibiotics or fewer, and 22 of these were isolated before 1998.
With the exception of two strains exhibiting the AMP-TCY-CHL-
ERY-KAN-NAL-STR-SXT-PB pattern, 74.0% (37/50) of the
non-toxigenic strains were resistant to four antibiotics or fewer
without obvious temporal distribution. Furthermore, 16 of these
non-toxigenic strains were resistant to ampicillin, erythromycin,
polymyxin B and streptomycin, thus representing the major MDR
pattern for non-toxigenic strains. Only two toxigenic and five non-
toxigenic strains were resistant to fewer than two antibiotics and
none of the isolates were pan-susceptible to all 16 antibiotics
tested. In short, the toxigenic strains exhibited a common pattern
of resistance to erythromycin, polymyxin B, streptomycin,
trimethoprim-sulfamethoxazole before 1997, with the subsequent
emergence of toxigenic strains exhibiting a predominant MDR
pattern of AMP-TCY-CHL-ERY-KAN-NAL-STR-SXT-PB after
1998. In contrast, the non-toxigenic strains exhibited less antibiotic
resistance than the toxigenic strains with fewer changes in the
pattern of resistance over time.
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and O139 Strains Isolated during the Same Period
Antibiotic resistance to nine antibiotics (ampicillin, ceftriaxone,
nalidixic acid, ciprofloxacin, chloramphenicol, tetracycline, doxy-
cycline, azithromycin and trimethoprim-sulfamethoxazole) was
compared in toxigenic V. cholerae O1 (from our database) and
O139 strains isolated over the same period from 1993 to 2009.
Interestingly, O1 strains exhibited significantly lower rates of
resistance to eight antibiotics compared with the O139 strains,
with the highest rate of resistance (32.3%) detected to trimetho-
prim-sulfamethoxazole (Fig. 2). Few toxigenic O1 strains were
resistant to ampicillin, chloramphenicol and azithromycin, where-
as resistance to these antibiotics was common for toxigenic O139
strains. Of the toxigenic O1 strains, 56.0% were pan-susceptible to
all 9 antibiotics tested, while this characteristic was not observed in
any of the O139 strains. Of the O1 strains, 22.8% were resistant to
more than one antibiotic, and only three O1 strains exhibited the
most comprehensive multidrug resistance pattern of ampicillin,
nalidixic acid chloramphenicol, tetracycline and trimethoprim-
sulfamethoxazole, which was commonly observed among the
O139 strains.
Pulsed-field Gel Electrophoresis Patterns of V. cholerae
O139 Isolates
Pulsed-field gel electrophoresis (PFGE) was used for subtyping
of strains to investigate the clonality or genetic variation of
serogroup O139 isolates. PFGE of Not I digested chromosomal
DNA from a subset of 177 isolates generated 101 PFGE patterns
(Fig. 3). The most common PFGE pattern, CN0002, was detected
for 20 toxigenic isolates, with 14 of these exhibiting the
predominant MDR pattern of AMP-TCY-CHL-ERY-KAN-
NAL-STR-SXT-PB. In contrast to this MDR pattern, four strains
were susceptible to trimethoprim-sulfamethoxazole and the other
two isolates were susceptible to chloramphenicol. The second most
common PFGE pattern, CN0005, contained 16 isolates, 12 of
which showed the MDR pattern of AMP-TCY-CHL-ERY-KAN-
NAL-STR-SXT-PB. Other PFGE patterns were represented by
fewer than 10 isolates, and 83 of the 101 isolates showed different
PFGE patterns, indicating the great genetic heterogeneity of V.
cholerae O139 isolates in China. Unlike the dominant MDR
patterns of antibiotic resistance, the toxigenic O139 strains did not
exhibit a dominant genotype associated with PFGE patterns.
Distribution of the Class I Integron, Super Integron and
SXT Element
The spread of multidrug resistance is facilitated by horizontal
transfer via self-transmissible mobile elements [24]. In order to
characterize the prevalence of genetic elements associated with
multidrug resistance in V. cholerae O139 strains, a panel of PCR
primers was designed to detect the class I integron, class IV
integron and SXT element. The superintegron was identified in all
of the O139 isolates by detection of the int IV gene. PCR detection
of int I showed that 71.7% (208) of the toxigenic V. cholerae O139
strains were positive for the class I integron, while only 6% (3/50)
of the non-toxigenic strains were positive. As shown in Figure 4
and Table S1, the class I integron was first identified in a cholera
patient isolate in 1993. More than half of the O139 strains isolated
each year since 1998 have been found to contain the class I
integron, with rates ranging from 54.3% to 93.3%, indicating
significant dissemination of this integron. No obvious increasing
trend was identified in the prevalence of the class I integron and
year after 1998. PCR assays were designed to detect the variable
Table 1. Antibiotic susceptibility patterns of toxigenic and non-toxigenic V. cholerae O139 isolates.
Antibiotic
Breakpoints
(mg/ml) Toxigenic (n=290) Non-toxigenic (n=50)
R(%) S(%) R(%) S(%)
Ampicillin S,=8R.=32
a 211(72.7) 79(27.3) 31(62.0) 19(38.0)
Cephalothin S,=8R.=32
b 46(15.9) 244(84.1) 3(6.0) 47(94.0)
Cefuroxime S,=8R.=32
b 0(0) 290(100.0) 0(0) 50(100.0)
Ceftriaxone S,=8R.=64
b 0(0) 290(100.0) 0(0) 50(100.0)
Cefixime S,=1R.=4
b 0(0) 290(100.0) 0(0) 50(100.0)
Nalidixic acid* S,=16R.=32
b 241(83.1) 49(16.9) 13(26.0) 37(74.0)
Ciprofloxacin S,=1R.=4
b 16(5.5) 274(94.5) 0(0) 50(100.0)
Tetracycline* S,=4R.=16
a 242(83.4) 48(16.6) 8(16.0) 42(84.0)
Doxycycline S,=4R.=16
b 39(13.5) 251(86.5) 1(2.0) 49(98.0)
Chloramphenicol* S,=8R.=32
a 193(66.5) 97(33.5) 5(10.0) 45(90.0)
Erythromycin S,=.5R.=8
b 273(94.1) 17(5.9) 49(98.0) 1(2.0)
Azithromycin* S,=2R.=8
b 146(50.3) 144(49.7) 1(2.0) 49(98.0)
Kanamycin* S,=16R.=64
b 231 (79.6) 59(20.4) 6(12.0) 44(88.0)
Streptomycin S,=4R.=16
b 284(97.9) 6(2.1) 44(88.0) 6(12.0)
Polymyxin B S,=2R.=4
b 287(99.0) 3(1) 43(86.0) 7(14.0)
Trimethoprim-
Sulfamethoxazole*
S,=2R.=4
a 263(90.7) 27(9.3) 16(32.0) 34(68.0)
aBreakpoints are based on the CLSI standards for V. cholerae.
bOther breakpoints refer to the CLSI criteria for Enterobacteriaceae.
R: includes intermediate and resistance; S: sensitivity.
A single asterisk (*) indicates that the rates of resistance among the toxigenic O139 strains was significantly different (P,0.01, x
2 test) from the non-toxigenic strains.
doi:10.1371/journal.pone.0038633.t001
Multiple Antibiotic Resistance in V. cholerae O139
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38633region of the class I integron and yielded four fragments of
different sizes. The class I integron with the typical gene cassette of
1 kb was present in 191 isolates, which contained the aadA2 gene
cassette encoding resistance to streptomycin by sequencing. An
amplicon of 1.8 kb was amplified in 15 strains isolated from 1998
to 2009 and were shown to contain dfrA12, which encodes the
gene for resistance to trimethoprim, orfF (unknown function) and
aadA2. An amplicon of 2.3 kb was detected in only one O139
Figure 1. Trends in antibiotic resistance among toxigenic V. cholerae O139 strains isolated from 1993 to 2009. Isolates from 1994 to
1997 were merged as one group for their less amounts of strains in each year. A and B: schematic of the dynamics of resistance to antibiotics and
cefuroxime, ceftriaxone and cefixime. Non-resistant strains are not listed. AMP: ampicillin, CEP: cephalothin, NAL: nalidixic acid, CIP: ciprofloxacin, CHL:
chloramphenicol, TCY: tetracycline, DOX: doxycycline, AZM: azithromycin, KAN: kanamycin, STR: streptomycin, ERY: erythromycin, SXT: trimethoprim-
sulfamethoxazole, PB: polymyxin B.
doi:10.1371/journal.pone.0038633.g001
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dfrA27 and aadA16, and showed high homology with the sequence
of the class I integron in the plasmid pRJ35C of a non-O1/non-
O139 strain. The class I integron with gene cassettes of
approximately 2.0 kb were detected in four strains that contained
the arr-2 and aadA3C genes, which was identical to the sequence of
the pIP1202-like plasmid in one of the O139 strains [17].
PCR assays revealed that 97.6% of the toxigenic strains
contained the SXT element, while this element was present in
only 26.0% of the non-toxigenic strains. As the genes mediating
resistance to cholramphenicol, streptomycin and trimethoprim-
sulfamethoxazole usually located in the SXT element, we chose
these three antibiotic resistances as confounding factors. Stratified
analysis revealed significantly higher rates of SXT element in the
toxigenic strains than nontoxigenic strains in each stratified group
(Supplement Table S2). The SXT element was present in all O139
strains first identified in China in 1993 and the rates of SXT
element positive strains has remained at greater than 90.0% from
1993 to 2009. The region containing antibiotic resistance genes in
the SXT element was sequenced and analyzed, revealing the
presence of the dfr18, floR, sulII, strA and strB genes among a few
isolates. One strain was negative for dfr18 and all five antibiotic
resistance genes were lost in another strain. Both of these deletions
have been reported previously [22].
Discussion
Antibiotics are often used in combination with rehydration
therapy. This approach is thought to relieve the symptoms of
cholera faster than rehydration treatment alone, in addition to
shortening disease duration and reducing the transmission of
infectious V. cholerae [24]. However, wide usage of antibiotics has
increased the sporadic appearance of resistance and multidrug
resistant strains are a serious cause for concern.
A number of studies have been reported high prevalence of V.
choleraeO139strainsresistanttonumerousantibioticsrecently.Inthis
study, antibiotic resistance patterns were surveyed among V. cholerae
O139strainsisolatedinChinafrom1993to2009usingapanelof16
antibiotics. Broad MDR was detected especially compared with O1
epidemic strains. A few of the more recently isolated O139 strains
isolated were resistant to ciprofloxacin and doxycycline, indicating
the careful use of doxycycline as an appropriate antibiotic for
treatment of O139 cholera. The spectrum of V. cholerae O139
resistance to various antibiotics was narrower at the beginning of its
emergence,withasuddenbroadeningoftheresistanceoftoxigenicV.
cholerae O139 to various antibiotics in1998, since when the
predominant MDR pattern of AMP-TCY-CHL-ERY-KAN-NAL-
STR-SXT-PB has spread to large areas of southeastern China,
resulting into a severe MDR situation which requires extensive
attention.However,thegradualincreaseinresistanceovertimewas
not obvious. Although most strains were sensitive to the new
generation of antibiotics, such as ciprofloxacin, doxycycline and
azithromycin, the emergence of resistance to these antibiotics may
lead to widespread resistance.
The toxigenic O139 strains exhibited significantly higher rates of
resistance to nalidixic acid, trimethoprim-sulfamethoxazole, tetra-
cycline, chloramphenicol, azithromycin and kanamycin compared
with the non-toxigenic strains. Although the non-toxigenic O139
strains do not cause cholera epidemics and are therefore of less
significance to public health, these strains represent clones which
toxigenicO139strainsoriginatefromandpossessmuchhigherlevels
of genetic polymorphism [25]. It is speculated that the toxigenic
strains are more likely to maintain antibiotic resistance in human
infectionsasaresultoftheselectivepressureoftherapeutictreatment,
whilethenon-toxigenicstrainsaremaintainedinthenaturalstatein
the environment with less antibiotic contact. Furthermore, higher
rates of resistance to azithromycin have been detected during some
years,thusraisingconcernsthatregardinguseofthisdrug,despitethe
Figure 2. Comparison of antibiotic resistance among toxigenic V. cholerae O1 and O139 strains isolated from 1993 to 2009. With the
exception of ceftriaxone, O1 strains exhibited significantly lower resistance rates to eight antibiotics compared with O139 strains (P,0.01, Wilcoxon
rank sum test or x
2 test). AMP: ampicillin, CRO: ceftriaxone, NAL: nalidixic acid, CIP: ciprofloxacin, CHL: chloramphenicol, TCY: tetracycline, DOX:
doxycycline, AZM: azithromycin, SXT: trimethoprim-sulfamethoxazole.
doi:10.1371/journal.pone.0038633.g002
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reported [21].
The spread of MDR V. cholerae O139 strains may be facilitated
by the horizontal mobilization of drug resistance genetic elements,
such as the class I integron and SXT element [12]. In contrast to
V. cholerae O1, the initial V. cholerae O139 isolates harbored the
SXT conjugative element, mediating resistance to streptomycin
and trimethoprim-sulfamethoxazole [13]. As previously reported,
many O139 strains isolated around the world have acquired the
SXT element [13,22,26]. Previous studies have also demonstrated
that horizontal dissemination of the SXT element is regulated by
the bacterial SOS response, which can be induced by ciprofloxacin
[27]. This suggests that antibiotics promote the spread of antibiotic
resistance genes, resulting in high antibiotic resistance. In this
study, the spread of the genetic determinants of resistance, such as
the class I integron and the SXT element, were generally
synchronized with the trend of increasing antibiotic resistance,
indicating a close correlation between genotype and phenotype in
V. cholerae O139 strains.
An interesting finding of this study was the obvious differences
in antibiotic resistance rates and patterns in O139 and O1 strains
isolated during the same years, which further suggests separated
lineage evolution between these strains. O1 strains are responsible
for large-scale outbreaks and prolonged epidemics, whereas O139
strains predominantly cause sporadic cases and foodborne
outbreaks in China, such as food poisoning. Studies that compare
Figure 3. PFGE profiles (Not I) obtained from 177 V. cholerae O139 strains isolated in China from 1993 to 2009. PFGE patterns (101) are
clustered, of which PFGE pattern with 1 strain are not listed.
doi:10.1371/journal.pone.0038633.g003
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environmental distribution. It was reported that V. cholerae O1
consistently achieved higher abundances than V. cholerae O139 in
colonizing adults of each copepod species as well as the multiple
life stages of E. affinis [28]. The difference in colonization may be
significant in the general predominance of V. cholerae O1 in cholera
epidemics in rural Bangladesh where water supplies are taken
directly from the environment. Differences of reported cholera
cases caused by O1 and O139 may exist in resource utilization and
responses to changing environmental conditions in the aquatic
habitat [28]. The reason for the significant variance in the
antibiotic resistance observed in V. cholerae O1 and O139 strains is
not clear, although this is partially explained by the fact that the
O139 strains exhibited high resistance at its emergence in 1993.
The threat of resistance transfer from MDR O139 strains to O1
exists, especially in areas of mixed O139 and O1 cholera
epidemics.
It has been speculated that antibiotic therapy is not the principal
cause of the generation of MDR in O139 strains based on the
observation of predominantly sporadic cases, diverse clones,
occasional outbreaks which quickly disappeared in China and
relatively low resistance rates of coexistent O1 epidemic strains.
Furthermore, no obvious trend of consecutive resistance over time
has been observed, in contrast to the complex MDR patterns
present in strains isolated in different years. Moreover, with the
exception of active transfer of mobile elements carrying resistant
genes, the complex clones of serogroup O139 may also contribute
to the complexity of antibiotic resistance patterns of O139 strains.
It is speculated that the spread of the O139-antigen among
different progenitors of V. cholerae, combined with genetic
rearrangements and natural selection, results in different lineages
of O139 strains [12]. Some studies showed continuous genetic
changes in V. cholerae O139 based on ribotyping and CTX
genotyping [5,6,8,9,12]. Diverse PFGE patterns of O139 isolates
were observed in this study. MDR was also found in the
environmental non-toxigenic O139 strains in this study, indicating
that horizontal transfer of the CTX element may also generate
new clones of toxigenic O139 strains with MDR.
In conclusion, the V. cholerae O139 strains isolated in China
exhibit a broad spectrum of resistance to numerous antibiotics,
with multidrug resistant patterns of to five or more antibiotics
found to be common in the toxigenic strains. It can be speculated
that the high heterogeneity and rapid clonal change of O139
strains results in the rapid shift of MDR patterns. Although O139
cholera is still confined to Asia with no large-scale and prolonged
epidemics, the threat to public health posed by MDR O139 strains
still exists. Furthermore, the possibility of resistant gene transfer to
O1 serogroup and even other species requires a significant
concern. Continuous monitoring of the changing trends in
antibiotics resistance patterns of O139 serogroup strains may
provide the basis of strategies for the control of new cholera
pathogens.
Materials and Methods
V. Cholerae Strains
Using stratified sampling of cases identified in different years
from 1993 to 2009, a total of 340 V. cholerae O139 strains used in
this study were randomly selected from records available at the
Centers for Disease Control and Prevention in China. As a Class A
infectious disease defined by the Law on the Prevention and
Treatment of Infectious Diseases in China, the records included
the O139 strains isolated from almost all cholera cases in China.
Eighteen V. cholerae strains were isolated from the first outbreak in
Xinjiang in 1993. A total of 10 strains isolated from the few O139
cholera cases reported from 1994 to1997 were included in this
study. Two hundred and fifty-six O139 strains included in this
study were obtained from small-scale outbreaks or sporadic cases
after 1997 (foodborne outbreaks became common after 1997). A
single strain was selected when a group of strains was obtained
from one outbreak. In this study, 56 strains were isolated from
environmental water and animals (predominantly seafood and
turtles) in southeastern China from 1998 to 2009.
Antibiotic Susceptibility Tests
Antibiotic susceptibility tests were performed using the micro-
broth dilution method according to the guidelines of the current
Clinical and Laboratory Standards Institute (CLSI). Sixteen
different antibiotics chosen by antimicrobial mechanism and
clinical usage for V. cholerae (Sigma, St. Louis, MO,USA) were
tested in this study including ampicillin (AMP), cephalothin (CEP),
cefuroxime (CXM), ceftriaxone (CRO), cefixime (CFM), tetracy-
cline (TCY), doxycycline (DOX), trimethoprim-sulfamethoxazole
(SXT), kanamycin (KAN), streptomycin (STR), nalidixic acid
(NAL), ciprofloxacin (CIP), chloramphenicol (CHL), erythromycin
(ERY), azithromycin (AZM) and polymyxin B (PB). Multidrug
Figure 4. Prevalence of the class I and class IV integrons and the SXT element in toxigenic O139 strains isolated from 1993 to 2009.
doi:10.1371/journal.pone.0038633.g004
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more classes of antibiotics. Escherichia coli ATCCH25922 and
Staphylococcus aureus ATCCH29213 were used as controls in
microbroth dilution antibiotic susceptibility tests and results were
analyzed with WHONET 5.4 software (WHO Collaborating
Centre for the Surveillance of Antibiotics Resistance, Geneva,
Switzerland).
Molecular Subtyping
Pulsed-field gel electrophoresis (PFGE) is a high-performance
molecular subtyping method that has been used for V. cholerae
previously [29]. Briefly, chromosomal DNA isolated from
overnight bacterial cultures was digested overnight with Not Ia t
37uC. The digested fragments were electrophoretically separated
using a CHEF-DR III system (Bio-Rad, USA). Electrophoresis
conditions were as follows: 6 v/cm at 14uC and pulse times
ramped from 2 s to 10 s for 13 hours followed 6 v/cm ramped
from 20 s to 25 s for a further 6 h. Images were captured using the
Gel Doc 2000 system (Bio-Rad, USA) and the PFGE patterns
were analyzed using the BioNumerics software package 4.0
(Applied Maths, Belgium). Using this technique, a subset 177 of
340 V. cholerae O139 strains were chosen for analysis of the genetic
variation among isolates of different geographic areas.
PCR and Sequencing of the Class I Integron
The presence of the cholera toxin, class I integron, class IV
integron and SXT element was screened by PCR amplification
using the primers listed in Table 2. The int I primer pair was
chosen to amplify the integrase (int I) as a marker of the presence of
the class I integron. Primer pairs 59CS-F and 39CS-R and qacE-F
and sul1-R were used to amplify and sequence the variable region
and 39 conserved segment of the integron, respectively. Primer
pairs specific for the int IV and intsxt, were used to detect the class
IV integron and SXT element respectively. Based on the genes
encoding resistance in the SXT element reported previously [13],
five primer pairs were used to amplify a product of approximately
17.2 kb in size containing five genes (dfr18, floR, sulII, strA and strB)
in the SXT element.
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